Loading
Latest filing published 20 Aug 2019 for Acasti Pharma Inc., €2,041.
Jean-Marie Canan discloses dealings in Acasti Pharma Inc. to SEDI. Over a trading history stretching from 12 July 2016 to 19 August 2019, the count stands at 6 filings.
No open-market sale appears; the market trades are 4 purchases worth €52k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Since January 2019: 2 purchases and no sales on the market.
The median purchase comes to €8,055. The 4 purchases reviewed show no overlap with other insiders buying the same stock within a month.
The latest filing, published on 20 August 2019, reports an open-market purchase of €2,041 in Acasti Pharma Inc. Typically, a trade is published a median of 3 days after it takes place. That lag is the time during which only the insider knows about the trade. Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations